The number of cases of gonorrhea has increased sharply in the last ten years in Sweden and in 2024 around 4,300 cases were detected. The disease, which is sexually transmitted, is very contagious and the problem of resistant variants has become increasingly serious globally. Globally, around 82 million people are infected each year, according to the WHO.
Now a study is presented that compared treatment with zoliflodacin, a new type of antibiotic that is given as a single dose in tablet form.
The study, published in the journal Lancet , involved around 900 people from five countries. They were randomly assigned to receive either a tablet containing zoliflodacine or standard treatment consisting of two different antibiotics, one of which is given as an injection. The effectiveness of the new drug was comparable to the other treatment.
Globally, resistance development has become a problem, so researchers hope that this could be another weapon to treat the disease. The US FDA is expected to announce soon whether the treatment will be approved.
Petra Hedbom/TT
Facts: Gonorrhea
TT
Gonorrhea is an infection caused by a bacterium. The infection can be transmitted through vaginal intercourse, anal intercourse, or oral sex.
The most common symptoms are burning when you urinate, discharge, spotting, or pain. However, in many cases, gonorrhea is asymptomatic.
The best protection against gonorrhea is a condom.
Gonorrhea can cause inflammation of the fallopian tubes, epididymides, or prostate if it spreads. This can make it more difficult for you to get pregnant.
Source: 1177
